🇺🇸 FDA
Pipeline program

YN001

YN001-001

Phase 1 small_molecule completed

Quick answer

YN001 for Cardiovascular Diseases is a Phase 1 program (small_molecule) at Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Indication
Cardiovascular Diseases
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials